Underuse of clozapine in treatment-resistant schizophrenia, Advances in Psychiatric Treatment, July 2011 17: pp. 250-255 Himanshu Mistry and David Osborn Abstract: Up to a third of patients with schizophrenia develop treatment resistance. Clozapine has been established as the most effective antipsychotic medication for treatment-resistant schizophrenia. However, it is significantly underutilised in this population. Possible reasons [...]
Filed under: Clozapine, Schizophrenia | Tagged: clozapine, lack of experience, risk of agranulocytosis, treatment-resistant schizophrenia | Comments Off
